ASCIA guidelines for prescribing an adrenaline autoinjector
Published in NPS RADAR
Date published: About this date
This page contains additional content relating to the article Adrenaline autoinjector (Anapen) for acute allergic anaphylaxis, published 1 August 2010.
ASCIA* guidelines for prescribing an adrenaline autoinjector
|
ALWAYS RECOMMENDED |
|
|
History of anaphylaxis (if patient is considered to be at continuing risk) |
|
|
Anaphylaxis A rapidly-evolving, generalised multisystem allergic reaction. Characterised by one or more symptoms or signs of respiratory and/or cardiovascular involvement and involvement of other systems such as the skin and/or gastrointestinal tract. |
|
|
Respiratory symptoms
|
Cardiovascular symptoms
|
|
SOMETIMES RECOMMENDED |
|
|
History of a generalised allergic reaction AND one or more risk factors |
|
|
Generalised allergic reaction Characterised by one or more symptoms or signs of skin and/or gastrointestinal tract involvement without respiratory and/or cardiovascular involvement. |
|
|
Skin symptoms
|
Gastrointestinal symptoms
|
|
Risk factors
|
|
|
NOT NORMALLY RECOMMENDED |
|
|
|
*Abbreviated from ASCIA (the Australasian Society of Clinical Immunology and Allergy) guidelines for adrenaline autoinjector prescription